Pediatric Device Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhaeos, Inc Receives $1 5 Million Blueprint MedTech Grant from the NIH to Transform Hydrocephalus Management

Rhaeos, Inc Receives $1 5 Million Blueprint MedTech Grant from the NIH to Transform Hydrocephalus Management
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNational science foundationNational capital consortium for pediatric device innovationPediatric hydrocephalus foundationNational institutes of healthRhaeos incNational institute of neurological disordersPrnewswire rhaeos incCoast consortium for technology innovation in pediatricsSteele foundation for hopePediatric device consortiumNorthwestern universityFederal awardNational institutesNational instituteNeurological disorders

Rhaeos Raises $10 5M in Series A Funding to Launch Novel Hydrocephalus Shunt Monitor and Accelerate Pipeline Product Development

/PRNewswire/ Rhaeos®, Inc. (Rhaeos), a clinical stage medical device company focused on addressing an unmet need in the care of people with hydrocephalus,.

Joe exnerDavidd limbrick jrAnna lisa someraPediatric device consortiumCoast consortium for technology innovation in pediatricsSteele foundation for hopeNational institutes of healthNational capital consortium for pediatric device innovationNational science foundationWashington university school of medicineRhaeos incPediatric hydrocephalus foundationHydrocephalus association fact sheetNorthwestern universityNational institute of neurological disordersSteele foundation

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

/PRNewswire/ Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its.

United statesUniversity of massachusetts medical schoolTufts medical centerQureshi ahmadJohn konsinPediatric device consortiumHuman developmentNational capital consortium for pediatric device innovationPediatric trials network steering committeeDrug administrationPharmaceuticals for childrenUniversity of alabama at birminghamPrapela incNational institute of child healthPrnewswire prapela incDevice designations

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threate.

United statesUniversity of massachusetts medical schoolTufts medical centerJohn konsinHuman developmentPediatric device consortiumNational capital consortium for pediatric device innovationDrug administrationUniversity of alabama at birminghamNational institute of child healthPrnewswire prapela incPrapela incDevice designationsBreakthrough device designationDevice designationNational institute

PRAPELA RECEIVES FDA S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY

/PRNewswire/ Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its.

United statesUniversity of massachusetts medical schoolTufts medical centerQureshi ahmadJohn konsinPediatric device consortiumHuman developmentNational capital consortium for pediatric device innovationPediatric trials network steering committeeDrug administrationPharmaceuticals for childrenUniversity of alabama at birminghamPrapela incNational institute of child healthPrnewswire prapela incDevice designations